Wenjie Luo

Phase I dose escalation study of the PI3kinase pathway inhibitor BKM120 and the oral poly (ADP ribose) polymerase (PARP) inhibitor olaparib for the treatment of high-grade serous ovarian and breast cancer

Ursula A. Matulonis, Gerburg M. Wulf, William T. Barry et al. · Annals of Oncology · 2016 · 220 citations · Full text

Medicine, Oncology, Pharmacology +15

Overall survival and updated progression-free survival outcomes in a randomized phase II study of combination cediranib and olaparib versus olaparib in relapsed platinum-sensitive ovarian cancer

J.F. Liu, William T. Barry, Michael J. Birrer et al. · Annals of Oncology · 2019 · 189 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

LncRNA RP11-89 facilitates tumorigenesis and ferroptosis resistance through PROM2-activated iron export by sponging miR-129-5p in bladder cancer

Wenjie Luo, Jun Wang, Wenhao Xu et al. · Cell Death and Disease · 2021 · 180 citations · Full text

Medicine, Molecular Biology, Oncology +17

<i>2H</i>‐Azirines: Recent Progress in Synthesis and Applications

Fen Xu, Fan‐Wang Zeng, Wenjie Luo et al. · European Journal of Organic Chemistry · 2024 · 43 citations

Natural Sciences, Chemistry, Medicinal Chemistry +14

Injectable Therapeutic Organoids Using Sacrificial Hydrogels

Ninna S. Rossen, Priya N. Anandakumaran, Rafael zur Nieden et al. · iScience · 2020 · 34 citations · Full text

Engineering, Bioengineering, Cell Biology +17